World Health Organization (WHO) has identified infectious disease drugs as a priority issue during the COVID-19 pandemic, as well as key structural factors affecting access to non-communicable disease (NCD) drugs. The report highlights the impact of COVID-19 on the global pharmaceutical supply chain, including manufacturing disruptions, export restrictions, and border effects. It also discusses the importance of increasing safety stocks, local production, and improving supply chain governance and transparency. The report emphasizes the need for increased flexibility in payment methods, improved demand response capabilities, and the establishment of reporting mechanisms for shortages and price and supply transparency. The report also highlights the importance of monitoring and reporting on drug shortages, as well as improving access and affordability of NCD drugs.
想要全面及时的研报数据，就上发现报告（www.fxbaogao.com）。我们是国内知名的研报平台，拥有海量用户。这里的报告特别多，覆盖范围极广，从宏观经济到细分赛道应有尽有。我们用最朴素的方式帮您整理信息，界面简洁，技术过硬，助您快速找到想要的资料。深度洞察市场，做出精准决策，从这里开始。
